Abdominal muscle activity in sleep apnea during continuous positive airway pressure titration.

Chest

Service de Physiologie, Explorations Fonctionnelles, Institut National de la Santé et de la Recherche Médicale, Créteil, France.

Published: August 2001

Study Objectives: The aim of this study was to investigate whether presence of expiratory abdominal muscle activity (EAMA) in obstructive sleep apnea syndrome (OSAS) patients during nasal continuous positive airway pressure (nCPAP) is due to either nCPAP overprescription or nCPAP underprescription.

Design: Airflow, esophageal pressure (Pes), and gastric pressure (Pga) were routinely measured during polysomnography aimed at determining the optimal nCPAP level, and the magnitude of EAMA was evaluated in relation to the nCPAP level and to the conventional indexes of upper-airway obstruction used during nCPAP titration.

Patients: The study was performed 12 patients with OSAS.

Results: Six patients displayed sustained EAMA, ie, EAMA lasting > 3 min, and characterized by a decrease in abdominal diameter and a paradoxical rise in Pga during expiration. In all six patients, EAMA decreased gradually as nCPAP neared optimal levels, and then disappeared when the optimal nCPAP level was achieved. The decrease in EAMA as nCPAP increased was associated with an increase in minute ventilation, decreases in both inspiratory and expiratory resistance, a decrease in Pes swing, and the normalization of the inspiratory flow contour.

Conclusions: We conclude that the EAMA observed in some OSAS patients might be an indirect marker of upper-airway obstruction, and that the presence of EAMA during nCPAP titration might indicate a suboptimal nCPAP level rather than a deleterious effect of nCPAP.

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.120.2.390DOI Listing

Publication Analysis

Top Keywords

ncpap level
16
ncpap
12
abdominal muscle
8
muscle activity
8
sleep apnea
8
continuous positive
8
positive airway
8
airway pressure
8
eama
8
osas patients
8

Similar Publications

Background: Respiratory Distress Syndrome (RDS) is the most common complication of preterm neonates. It remains one of the major public health concerns that contribute to neonatal mortality and morbidity, especially in Africa, where 80% of neonatal mortality is estimated to be caused by preterm complications. Nasal Continuous Positive Airway Pressure (NCPAP) ventilation is the preferred mode of RDS treatment.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness and safety of various noninvasive ventilation (NIV) methods for treating Neonatal Respiratory Distress Syndrome (NRDS) after extubation.
  • Researchers used extensive database searches and analyzed 23 studies involving 2,331 neonates, focusing on outcomes like the need for reintubation and carbon dioxide retention.
  • Results showed that NHFOV, NIPPV, and N-BiPAP were significantly better than NCPAP in reducing reintubation rates, with NHFOV being the most effective for carbon dioxide clearance as well.
View Article and Find Full Text PDF

Background: Guidelines recommend non-invasive ventilatory (NIV) support as first-line respiratory support mode in preterm infants as NIV is superior to intubation and mechanical ventilation in preventing death or bronchopulmonary dysplasia. However, with an ever-expanding variety of NIV modes available, there is much debate about which NIV modality should ideally be used, how, and when. The aims of this work were to summarise the evidence on different NIV modalities for both primary and secondary respiratory support: nCPAP, nasal high-flow therapy (nHFT), and nasal intermittent positive airway pressure ventilation (nIPPV), bi-level positive airway pressure (BiPAP), nasal high-frequency oscillatory ventilation (nHFOV), and nasally applied, non-invasive neurally adjusted ventilatory assist (NIV-NAVA) modes, with particular focus on their use in preterm infants.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess how heated humidified high-flow nasal cannulas (HHHFNC) are used in level III neonatal intensive care units (NICUs) across Saudi Arabia, employing an online survey to gather data on availability, protocols, and patient demographics.
  • - Out of 47 NICUs surveyed, 35 responded, revealing that 46% had established guidelines for HHHFNC usage, and 51% used it across various gestational ages, mainly for weaning off nasal continuous positive airway pressure (nCPAP).
  • - While HHHFNCs are becoming more common in NICUs, the study highlighted a lack of standardized policies for their application, particularly for preterm infants.
View Article and Find Full Text PDF

Higher versus lower nasal continuous positive airway pressure for extubation of extremely preterm infants in Australia (ÉCLAT): a multicentre, randomised, superiority trial.

Lancet Child Adolesc Health

December 2023

Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia; Department of Paediatrics, Monash University, Melbourne, VIC, Australia. Electronic address:

Background: Extremely preterm infants often require invasive mechanical ventilation, and clinicians aim to extubate these infants as soon as possible. However, extubation failure occurs in up to 60% of extremely preterm infants and is associated with increased mortality and morbidity. Nasal continuous positive airway pressure (nCPAP) is the most common post-extubation respiratory support, but there is no consensus on the optimal nCPAP level to safely avoid extubation failure in extremely preterm infants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!